60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) started the day on Thursday, with a price increase of 24.06% at $1.65, before settling in for the price of $1.33 at the close. Taking a more long-term approach, SXTP posted a 52-week range of $1.03-$23.76.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 2.28%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 65.78%. This publicly-traded company’s shares outstanding now amounts to $1.77 million, simultaneously with a float of $1.52 million. The organization now has a market capitalization sitting at $2.92 million. At the time of writing, stock’s 50-day Moving Average stood at $2.6522, while the 200-day Moving Average is $4.9337.
60 Degrees Pharmaceuticals Inc (SXTP) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. 60 Degrees Pharmaceuticals Inc’s current insider ownership accounts for 14.30%, in contrast to 1.70% institutional ownership. According to the most recent insider trade that took place on Jan 31 ’24, this organization’s President and CEO bought 25,974 shares at the rate of 0.38, making the entire transaction reach 9,740 in total value, affecting insider ownership by 703,599. Preceding that transaction, on Jan 31 ’24, Company’s Director bought 200,000 for 0.38, making the whole transaction’s value amount to 75,000. This particular insider is now the holder of 424,934 in total.
60 Degrees Pharmaceuticals Inc (SXTP) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.44 per share during the current fiscal year.
60 Degrees Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 65.78% and is forecasted to reach -2.44 in the upcoming year.
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Trading Performance Indicators
Let’s observe the current performance indicators for 60 Degrees Pharmaceuticals Inc (SXTP). It’s Quick Ratio in the last reported quarter now stands at 2.73. The Stock has managed to achieve an average true range (ATR) of 0.41. Alongside those numbers, its PE Ratio stands at $2.60, and its Beta score is 4.67. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 6.64.
In the same vein, SXTP’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.63, a figure that is expected to reach -2.96 in the next quarter, and analysts are predicting that it will be -2.44 at the market close of one year from today.
Technical Analysis of 60 Degrees Pharmaceuticals Inc (SXTP)
If we take a close look at the recent performances of 60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP), its last 5-days Average volume was 3.23 million that shows progress from its year to date volume of 0.29 million. During the previous 9 days, stock’s Stochastic %D was recorded 35.15% While, its Average True Range was 0.4024.
Raw Stochastic average of 60 Degrees Pharmaceuticals Inc (SXTP) in the period of the previous 100 days is set at 10.00%, which indicates a major fall in contrast to 49.19% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 227.82% that was higher than 125.24% volatility it exhibited in the past 100-days period.
